Can tinnitus that began after starting Wellbutrin (bupropion) resolve?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Wellbutrin-Induced Tinnitus: Can It Resolve?

Yes, tinnitus that develops after starting Wellbutrin (bupropion) can resolve and is typically reversible upon dose reduction or discontinuation of the medication.

Evidence from FDA Drug Labeling

The FDA-approved labeling for Wellbutrin clearly documents tinnitus as a recognized adverse effect. In placebo-controlled trials for major depressive disorder, tinnitus occurred in 6% of patients on both 300 mg/day and 400 mg/day doses, compared to only 2% on placebo 1. In seasonal affective disorder trials, tinnitus occurred in 3% of patients on Wellbutrin XL versus less than 1% on placebo 1. This establishes a clear dose-related relationship and confirms bupropion as a causative agent for tinnitus.

Clinical Evidence of Reversibility

The most compelling evidence comes from a recent 2025 case report documenting a 45-year-old male who developed bilateral low-pitched humming tinnitus after his bupropion dose was escalated from 150 mg to 300 mg daily 2. The key findings were:

  • Tinnitus partially improved with dose reduction
  • Complete resolution occurred after drug discontinuation
  • No alternative causes were identified (normal audiometry, brain MRI, no history of ear disease or ototoxic medications)
  • The temporal correlation between dose escalation and symptom onset strongly suggested causality

This case demonstrates that bupropion-induced tinnitus is both dose-dependent and reversible 2.

Mechanism and Clinical Characteristics

While the exact mechanism remains uncertain, it likely involves altered dopaminergic or noradrenergic signaling within the auditory system 2. Bupropion has been documented to cause various auditory disturbances, with one case report from 1999 describing tinnitus as part of a constellation of neurological symptoms that resolved after drug discontinuation 3.

Clinical Management Algorithm

When tinnitus develops after starting or increasing Wellbutrin:

  1. Establish temporal relationship: Confirm the tinnitus began after drug initiation or dose escalation
  2. Rule out alternative causes: Perform targeted audiological evaluation if hearing loss is suspected 4
  3. Consider dose reduction first: If therapeutic benefit is needed, try lowering the dose 2
  4. Discontinue if necessary: If tinnitus is bothersome and persists despite dose reduction, discontinuation typically leads to complete resolution 2
  5. Monitor for resolution: Expect improvement within days to weeks after dose adjustment or cessation

Important Caveats

  • Tinnitus is listed as a known adverse effect in FDA labeling, making this a recognized drug-related phenomenon 1
  • The incidence is relatively low (3-6% depending on dose and indication) but significantly higher than placebo
  • Do not routinely obtain neuroimaging unless other concerning neurological features are present 4
  • While antidepressants are sometimes used to treat primary tinnitus with comorbid depression, they should not be routinely recommended for treating tinnitus itself 4

Prognosis

The prognosis for bupropion-induced tinnitus is excellent with appropriate intervention. The available evidence consistently demonstrates reversibility, particularly when the medication is discontinued or the dose is reduced 2. This distinguishes drug-induced tinnitus from chronic primary tinnitus, which often requires behavioral interventions like cognitive behavioral therapy for management 4.

References

Research

Bupropion mimics a transient ischemic attack.

The Annals of pharmacotherapy, 1999

Research

Clinical Practice Guideline: Tinnitus Update.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.